Skip to main content
. 2019 Apr 20;20(8):1948. doi: 10.3390/ijms20081948

Table 1.

Differential diagnosis of NAFLD. Several conditions associated with liver steatosis are shown in this table, with possible pathogenetic mechanisms and associated references.

Conditions Associated with Liver Steatosis Mechanism of Action References
Alcohol (>20 g/day (women) or >30 g/day (men)) Redox state shift: fatty acid oxidation inhibition, induction of lipogenesis
Altered VLDL secretion in the liver
[22]
HCV Altered VLDL secretion in the liver
Insulin resistance
Mitochondrial dysfunction and oxidative stress
[23]
Medications (e.g., methotrexate, corticosteroids, valproate) Fatty acid oxidation inhibition, induction of lipogenesis
Mitochondrial dysfunction
Impaired hepatic lipid secretion
Insulin resistance
[24]
Lipid metabolism disorders: a/hypo-betalipoproteinaemia, Wolman’s disease Impaired hepatic lipid secretion
Impaired hydrolysis of cholesteryl esters and triglycerides
[25,26]
Metal storage disorders: Wilson’s disease Copper-induced mitochondrial dysfunction [27]
Autoimmune hepatitis Drug-mediated effects [28]
Coeliac disease Weight gain on gluten-free diet
Impaired hepatic lipid mobilization
Intestinal malabsorption
[29]
Endocrine disorders: hypothyroidism, hypopituitarism, polycystic ovary syndrome Reduced hepatic lipid utilization
Insulin resistance
Impaired insulin secretion
[30,31,32,33]
Starvation, parenteral nutrition Impaired hepatic lipid secretion
Reduced mitochondrial beta-oxidation
[34]
Lipodystrophy Insulin resistance and ectopic fat accumulation [35]